Asprosin, a novel glucogenic adipokine: a potential therapeutic implication in diabetes mellitus.
Munevver Gizem HekimMuhammed Mirac KelestemurFunda Gulcu BulmusBatuhan BilginFerah BulutEbru GokdereMehmet Ridvan OzdedeHaluk KelestimurSinan CanpolatMete ÖzcanPublished in: Archives of physiology and biochemistry (2021)
Our novel findings implicate that asprosin may be a target molecule in preventing the development and complications of diabetes.